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Abstract
Introduction and hypothesis Little is known about dynamic
cell-matrix interactions in the context of pathophysiology
and treatments for pelvic organ prolapse (POP). This study
sought to identify differences between fibroblasts from
women with varying degrees of prolapse in reaction to
mechanical stimuli and matrix substrates in vitro.
Methods Fibroblasts from the vaginal wall of three patients
with POP Quantification (POP-Q) system stages 0, II, and
IV were stretched on artificial polymer substrates either
coated or not coated with collagen I. Changes in
morphology and anabolic/catabolic compounds that affect
matrix remodelling were evaluated at protein- and gene-
expression levels. Statistical analysis was performed using
one-way analysis of variance (ANOVA), followed by
Tukey-Kramer’s post hoc test.
Results POP fibroblasts show delayed cell alignment and
lower responses to extracellular matrix remodelling factors
at both enzymatic- and gene-expression levels compared
with healthy fibroblasts.
Conclusion POP fibroblasts, when compared with
healthy cells, show differential mechanoresponses on
two artificial polymer substrates. This should be taken
into account when designing or improving implants for
treating POP.
Keywords Cyclic mechanical loading . Matrix
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Introduction
Pelvic organ prolapse (POP) is a common multifactorial
disease with known risk factors and unclear pathogenesis.
POP is characterized by weakening of the pelvic floor and is
associated with serious inconveniences and reduced quality
of life (QOL) in almost 50 % of women >50 years of age.
Conservative therapies are not always possible or sufficient,
and reconstructive surgery with native tissue has high failure
rates. Of all treated patients, 30 % will experience recurrent
POP within the first 2 years of treatment [1, 2]. In the 1970s,
urogynecologists began using polymeric mesh, originally
designed to treat inguinal hernia, in an attempt to restore
tissue support in POP patients. However, complications
such as mesh contraction, exposure, or extrusion caused
such serious health problems that in July 2011, the US
Food and Drug Administration (FDA) issued a safety com-
munication about the use of transvaginal mesh in POP repair
[3, 4]. Thus, improved therapies are urgently needed but
their development are, however, hampered by a lack of
understanding of the pathophysiology of the disease, along
with sparse knowledge of the cause–effect relationships of
mesh failure in patient tissue [5, 6].
In recent years, there has been a growing interest in study-
ing tissue composition of patients with prolapse. Researchers
havemainly focused on characterizing the extracellular matrix
(ECM) of connective tissue that support the pelvic floor, such
as the vaginal wall [2, 7–11], the uterosacral ligaments [12,
13], and the pubocervical fascia [13, 14]. Different outcomes
have been reported, but the overall consensus is that the
connective tissue of the vaginal wall is abnormal in women
with POP [15]. The vaginal wall is one of the soft tissues that
is constantly being remodelled so it can withstand the different
forces applied to it during a woman’s lifetime. Thus, weaken-
ing of the pelvic floor could be caused by an imbalance in its
remodelling [2, 7, 8]. The presence of artificial substrates may
very well influence this process.
Tissue remodelling is a well-balanced process involving
several factors with different roles, with cells asmodulators. In
the vaginal wall, fibroblasts are mechanosensitive cells re-
sponsible for maintaining ECM homeostasis. They produce
molecules and control anabolic and catabolic processes to
remodel their surrounding matrix in response to mechanical
and biochemical stimuli. Compounds particularly involved in
ECM homeostasis include collagens (mainly types I and III),
collagen-degrading matrix metalloproteinases (MMPs), and
tissue inhibitors of metalloproteinases (TIMPs). MMPs are
involved in both normal and pathological ECM remodelling
processes throughout the body, including the pelvic floor. It
has been shown that the amounts of active MMP-2 [12, 13,
16] and/orMMP-9 [7, 17] are increased in tissue from patients
with POP in comparison with controls. However, we were
interested to see whether these MMPs are also increased when
cells are exposed to cyclic mechanical loading. Furthermore,
the question remains whether this enzymatic activity is affect-
ed by the presence of artificial polymeric substrates.
In order to answer these questions, our study was designed
to evaluate in vitro dynamic cell–matrix interactions that are
important for understanding the pathophysiology of and treat-
ments for POP. We hypothesized that fibroblasts from women
with different degrees of prolapse display different
mechanoresponses depending on the substrate encountered.
This hypothesis was tested by subjecting fibroblasts from
healthy women and those with mild or severe POP to cyclic
mechanical loading mimicking continuous respiration [18] on
artificial polymeric membranes both uncoated and coatedwith
collagen I. Changes in morphology and anabolic/catabolic
compounds that may affect remodelling of the ECM were
analyzed.
Materials and methods
Patient selection, tissue processing, and cell culture
Retrieval of biopsies was approved by the medical ethics
committees of two hospitals in The Netherlands: VU
University Medical Centre (Amsterdam) and Kennemer
Gasthuis Hospital (Haarlem), and informed consent was
obtained from all participants. Full-thickness biopsies
(1 cm2) of the anterior vaginal wall were obtained during
vaginal hysterectomy of one patient with mild [POP
Quantification (POP-Q) system, stage II] and one patient with
severe POP (POP-Q stage IV). A third woman, who was
operated for benign gynecological reasons, was selected as a
healthy control. For ethical reasons, the biopsy site of the latter
patient was the precervical region of the anterior vaginal wall.
Tissues were collected in phosphate-buffered saline (PBS) at
4 °C, and cells were isolated within 24 h under sterile condi-
tions. Fascia was scraped, cut into little pieces, and digested
with Liberase TM (final concentration 0.3 U/ml; Roche
Diagnostics, Mannheim, Germany) for 3 h at 37 °C and
constant agitation. After filtration with a 100-μm cell strainer
(BD Falcon, Franklin Lakes, NJ, USA), the pellet was
resuspended in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10 % fetal bovine serum (FBS),
100 U/ml penicillin, 100 μg/ml streptomycin, and 250 μg/ml
amphotericin-B. FBS was obtained from HyClone (South
Logan, UT, USA); the other culture components were obtained
from Gibco-Life Technologies (Paisley, UK) and Sigma
(St. Louis, MO, USA). Subsequently, cells were seeded on
six-well plates and grown in an incubator at 37 °C, 95 %
humidity, and 5 % carbon dioxide (CO2) until they reached
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60 % confluence. At that point, the cells were considered to be
at passage 0. Fibroblasts from passage 3–5 were used for
loading experiments.
Cyclic mechanical loading
Forty-eight hours before mechanical loading, fibroblasts were
seeded at a density of 150,000 cells/well on two artificial
polymer substrates: six-well uncoated or collagen I-coated sili-
cone Bioflex® plates (BioFlex, Flexcell International Corp.,
McKeesport, PA, USA). Just before loading, the cells were
refreshed using culture media containing 1 % FBS. The loading
regimewas applied using a Flexercell FX4000 system (Flexcell)
and consisted of 24 or 48 h of continuous cyclic mechanical
loading (CML) mimicking continuous respiration, as described
by Blaauboer and colleagues [18] (parameters: sinusoidal wave,
frequency 0.2 Hz, and maximum elongation 10 %). The
Flexercell device is widely used and has a vacuum pump that
pulls down the elastic membrane of the bioflex plates, stretching
the cells that are seeded on top accordingly. Fibroblasts cultured
under the same conditions but without loading served as static
controls. After the loading period, the cells were imaged using
the bright field of an inverted Leica DMIL microscope with a
DFC320 digital camera (Leica Microsystems, Wetzlar,
Germany), and samples were collected for F-actin staining,
MMP activity, protein content, and gene expression.
F-actin staining
For immunocytochemical staining of F-actin, cells were fixed
using 4 % formaldehyde, stained for F-actin with Alexa Fluor
488 phalloidin (Molecular Probes, Leiden, The Netherlands),
and imaged using an inverted Leica DMIL microscope
(Leica Microsystems), as previously described [19].
Enzymatic activity
After mechanical loading, conditioned media was collected,
and the gelatinolytic activity of MMP-2 and MMP-9 was
evaluated by zymography using 10 % Novex zymogram gel-
atin gel (Life Technologies) following manufacturers’ protocol.
Dark bands of gelatinolytic activity were visualized using an
eStain protein staining device (GeneScript, Piscataway, NJ,
USA). Images were acquired with Biospectrum AC Imaging
System (UVP, Cambridge, UK), and zymogram quantification
of band density was performed using Image J 1.44p software
(National Institutes of Health, USA). Quantitative data was
normalized to total protein content (see below).
Western blot analysis
Conditioned media after 48 h of loading were used to detect
protein levels of TIMP-2 by Western blot. Samples were
concentrated 2x by freeze drying, denatured for 5 min, and
reduced with dithiothreitol. Samples were separated by electro-
phoresis on a NuPAGE® Novex 4–12 % Bis-Tris gel and
transferred to iBlot® polyvinylidene fluoride (PVDF) mem-
brane (Life Technologies). For protein detection, monoclonal
antibody anti-TIMP-2 mouse (mAb T2-101; Calbiochem®,
Merck Millipore, Darmstadt, Germany) was used at a con-
centration of 1:500. Blots were blocked for 1 h at room
temperature with a blocking buffer [PBS with 0.5 %
Tween-20 and 1 % bovine serum albumin (BSA)], then
incubated with primary antibody in blocking buffer for 1 h
at room temperature, followed by overnight incubation at
4 °C. Bound antibodies were visualized with a horseradish
peroxidase-conjugated antibody goat anti-mouse (1:10,000)
and Supersignal West Pico Chemiluminescent kit (Thermo
Scientific, Rockford, IL, USA). Images were acquired with
Biospectrum AC Imaging System (UVP), and quantification
of band density was performed using Image J 1.44p
software (NIH).
Total protein quantification
For total protein quantification, cells were lysed in buffer
containing 50 mM Tris, pH7.5, 150 mM sodium chloride
(NaCl), 1mM sodium orthovanadate, 1 % Nonidet P-40,
0.1 % sodium deoxycholate, and ethylenediaminetetraace-
tate (EDTA)-free protease inhibitor mixture (Sigma-
Aldrich). Total protein content was determined using
Pierce BCA Protein Assay kit (Thermo Scientific) following
the supplier’s specifications. Quantification was performed
spectrophotometrically between 540–590 nm and using a
1,420 multilabel counter VICTOR2 (WALLAC, Turku,
Finland).
Gene expression
For gene expression, cells were lysed in a solution (1:100)
of β-mercaptoethanol (Sigma-Aldrich) and RA1 buffer
(Macherey-Nagel, Bioke, Leiden, The Netherlands).
According to the manufacturers’ instructions, total RNA
was isolated using NucleoSpin TriPrep kit (Bioke) to a final
concentration of 250 ng/ml and was reverse transcribed
using SuperScript VILO complementary DNA (cDNA) syn-
thesis kit (Life Technologies). Gene expression of alpha-1(I)
procollagen (Col1a1), alpha-1(III)procollagen (Col3a1),
matrix metalloproteinase-2 (MMP-2), TIMP-2, and the
housekeeping genes tyrosine 3-monooxygenase/tryptophan
5-monooxygenase activation protein, zeta polypeptide
(Ywhaz) and human ubiquitin C (hUBC) were evaluated
using the primers listed in Table 1 (Life Technologies), the
SYBR Green Reaction Kit following suppliers’ specifica-
tions (Roche), and measured by reverse transcription poly-
merase chain reaction (RT-PCR) in a Light Cycler 480
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device (Roche). Gene expression levels were normalized
using a factor derived from the equation √(Ywhaz x hUBC).
Crossing points were assessed using the Light Cycler
software (version 4) and plotted versus serial dilutions of
cDNA derived from a human universal reference total RNA
(Clontech Laboratories Palo Alto, CA, USA).
Statistical analysis
Three independent experiments were performed in dupli-
cate, and data are expressed as mean ± standard deviation
(SD). Statistical analysis was performed using one-way
analysis of variance (ANOVA) followed by Tukey–
Kramer’s post hoc test (Prism version 5.02, GraphPad
Software Inc., La Jolla, CA, USA). Differences were con-
sidered significant at the 5 % level (p<0.05).
Results
After 48 h of cyclic mechanical loading, morphological
analysis showed cell alignment perpendicular to the
force that was facilitated by collagen-coated surfaces,
with no apparent differences between healthy (Fig. 1b
and d) and POP (Fig. 2c and d) fibroblasts. At an
earlier time point (24 h), load-induced rearrangement
of F-actin fibers was completed for mild but not severe
POP fibroblasts (Fig. 2a vs. b). Static control cells
displayed random distribution independent of surface
(Fig. 1a and b).
To evaluate the effects of the different experimental con-
ditions on the capacity of the fibroblasts to remodel the
ECM, secreted MMP-2 and MMP-9 enzymatic activity were
evaluated at two time points (24 and 48 h). Total levels of
released MMP-2 by POP fibroblasts at 24 h were lower than
healthy control cells, independent of the surface substrate
(Fig. 3a). At the same time point, but only on uncoated
plates, cyclic mechanical loading induced activation of
MMP-2, which was more pronounced by healthy fibro-
blasts. Under static conditions, MMP-2 activation was only
observed in healthy control cells on uncoated plates (Fig. 3a
left blot). There was no apparent activation of MMP-2 on
collagen-I-coated plates, with the exception of a very faint
band of active MMP-2 on stretched mild POP fibroblasts
(Fig. 3a middle blot).
At a later time point (48 h), levels of released pro-
MMP-2 were similar on collagen-I surfaces, and no active
MMP-2 was found (Fig. 3b middle blot). On uncoated
plates, stretching of fibroblasts induced MMP-2 activation
that increased from 24 to 48 h. Such activation was lower
in POP fibroblasts compared with healthy controls
(Fig. 3b and b, left blot). Western blot analysis at 48 h
revealed the presence of TIMP-2 only in cells exposed to
collagen-coated plates without any apparent regulation by
loading (Fig. 3c). Released MMP-9 was below detection
levels.
As levels of released MMP-2 were higher after 48 h,
these data were quantified and normalized to total pro-
tein content. Quantitative data revealed that under static
conditions and regardless of the type of substrate, most
cells released similar amounts of pro-MMP-2 into the
extracellular environment (Fig. 3d and e). On uncoated
plates, mechanical loading induced MMP-2 activation
by all cell populations, as the ratios between active
and inactive (pro) MMP-2 forms were always >1, and
ANOVA showed that such an increment was significant
only in the case of healthy fibroblasts (p<0.01) (Fig. 3f). On
collagen-I-coated plates, quantitative data revealed similar
expression profiles of pro-MMP-2 and TIMP-2 in all groups
(Fig. 3e and g).
Table 1 Primer sequences used for reverse transcriptase polymerase chain reaction (RT-PCR)
Target gene Oligonucleotide sequence Annealing temperature (°C) Product size (bp)
Col1a1 Forward reverse 5′ TCCAACGAGATCGAGATCC 3′ 57 191
5′ AAGCCGAATTCCTGGTCT 3′
Col3a1 Forward reverse 5′ GATCCGTTCTCTGCGATGAC 3′ 56 279
5′ AGTTCTGAGGACCAGTAGGG 3′
MMP-2 Forward reverse 5′ GGCAGTGCAATACCTGAACA 3′ 56 253
5′ AGGTGTGTAGCCAATGATCCT 3′
TIMP-2 Forward reverse 5′ CTGAACCACAGGTACCAGAT 3′ 63 237
5′ TGCTTATGGGTCCTCGATG 3′
Ywhaz Forward reverse 5′ GATGAAGCCATTGCTGAACTTG 3′ 56 229
5′ CTATTTGTGGGACAGCATGGA 3′
hUBC Forward reverse 5′ GCGGTGAACGCCGATGATTAT 3′ 56 202
5′ TTTGCCTTGACATTCTCGATGG 3′
Col1a1 alpha-1(I)procollagen, Col3a1 alpha-1(III)procollagen, MMP-2 matrix metalloproteinase-2, TIMP-2 tissue inhibitor of metalloproteinases-
2, hUBC human ubiquitin C, Ywhaz tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide
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To detect differences at the gene-expression level, ECM-
remodelling-related genes Col1a1, Col3a1, MMP-2, and
TIMP-2 were chosen to evaluate the effects of cyclic me-
chanical loading and surface substrate after 48 h of treat-
ment. On uncoated plates, both mild and severe POP
fibroblasts showed significantly lower gene expression of
Col1a1 and Col3a1 when compared with healthy controls
(Fig. 4a and b). On the same substrate, gene expression of
Col1α1 was down-regulated by mechanical loading in
healthy but not in POP fibroblasts.MMP-2 expression levels
were similar in all fibroblasts, independent of loading con-
ditions (Fig. 4c and d). On collagen-I-coated plates, mild but
Fig. 2 On collagen-I-coated
plates, rearrangement of F-actin
fibers was completed after
24 h of loading for mild but
not for severe pelvic organ
prolapse (POP) fibroblasts.
Representative images of POP
fibroblasts F-actin fibers
showing cell alignment
perpendicular to the force (F)
on collagen-I-coated plates after
24 h (a and b) or 48 h (c and d)
of loading. F-actin fibers
stained with phalloidin
Bar 100 μm
Fig. 1 Cell attachment and
alignment is facilitated by
collagen I substrates.
Representative images of
healthy fibroblasts after 48 h of
cyclic mechanical loading
(CML) on uncoated (a, c) or
collagen-I-coated (b, d) plates.
Morphology shows random cell
distribution under static
conditions (−CML, a and b);
whereas stretching induced cell
alignment perpendicular to the
force (F), especially on
collagen-I-coated plates
(+CML, c and d). Images were
acquired with 10x objective of a
Leica microscope, bar is
100 μm
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not severe POP fibroblasts showed lower gene expression
levels of Col1a1, Col3a1, and MMP-2 when compared with
healthy controls (Fig. 4e, f and g). TIMP-2 expression levels
were similar in all fibroblasts, independent of loading or
coating conditions (Fig. 4h).
Discussion
In POP, tissue strength is lost, stiffness is increased [9–11],
and ECM quality is compromised [15]. Consequently, fibro-
blasts might be exposed to an abnormal matrix. The biome-
chanical environment may be further compromised if during
pelvic reconstructive surgery, stiff, nonresorbable polymeric
mesh is used to replace tissue function. We evaluated the
possible roles of CML and two surface substrates on the
functionality of healthy and mild and severe POP fibroblasts
using an in vitro dynamic model. We found variations of
fibroblast responses at morphological, enzymatic, and gene-
expression levels.
Cells respond to mechanical stimuli by remodelling their
actin cytoskeleton [20]. Our results show that all fibroblasts
were mechanoresponsive, as their actin cytoskeleton aligned
perpendicular to the force after 48 h of cyclic mechanical
loading, especially in the presence of collagen I. This find-
ing is consistent with previous reports that fibroblasts from
the pelvic floor completely align after being stretched for
48 h [21]. Differences between cell populations were seen
after 24 h of loading on collagen-I substrates, when visual-
ization of actin filaments revealed that alignment of severe
POP fibroblasts appear delayed in comparison with their
mild counterparts; also, released MMP-2 was lower in fi-
broblasts from POP patients compared with healthy control
cells. These effects seemed to disappear with time, as after
48 h of stretching, there was no apparent difference in cell
alignment, no activation of MMP-2, TIMP-2 protein levels
corresponded to pro-MMP-2, and no difference in gene
expression of MMP-2 or TIMP-2.
Interestingly, when fibroblasts were exposed to artificial
polymeric substrates (uncoated plates), clear differences
were seen in production and activation of MMP-2, TIMP-
2 could not be detected, and mechanical loading promoted
MMP-2 activation over time. After 48 h of loading, MMP-2
activation was significant only in healthy, not in POP, fibro-
blasts. Moreover, cells from women with prolapse showed
differential gene expression of anabolic but not catabolic
compounds: collagens I and III were lower in women with
Fig. 4 Relative expression of extracellular matrix (ECM)-remodelling-
related genes. Fibroblasts from healthy and mild, or severe pelvic organ
prolapse (POP) patients were subjected or not subjected to cyclic me-
chanical loading (+/−CML) on uncoated (a, b, c, and d) or collagen-I-
coated (e, f, g, and h) plates. Each column represents a different gene:
Col1a1 (a) and (e); Col3a1 (b) and (f); MMP-2 (c) and (g); TIMP-2 (d)
and (h). Values are normalized to housekeeping genes (Ywhaz and
hUBC), expressed as a percentage of healthy controls, and represent the
mean ± standard deviation (SD). *p<0.05, **p<0.01, ***p<0.001;com-
pared with the first bar, unless indicated otherwise
Fig. 3 Mechanical loading induced activation over time of matrix
metalloproteinase-2 (MMP-2) by fibroblasts seeded on uncoated
plates. Conditioned media of fibroblasts from healthy, mild, and severe
pelvic organ prolapse (POP) patients after 24 h (a) or 48 h (b and c) of
cyclic mechanical loading (CML) on uncoated or collagen-I-coated
plates was evaluated. Blots a and b are representative zymograms
showing MMP-2 activity; c Is a Western blot of conditioned media
(concentrated x2), showing that tissue inhibitor of metalloproteinase-2
(TIMP-2) was released by cells on collagen substrates only. Blots at
48 h of CML were analyzed with imageJ, and quantitative data was
normalized to total protein content. Quantitative data from zymograms
show levels of released pro-MMP-2 by fibroblasts on uncoated (d) or
collagen I-coated (e) plates, and the ratio between active and inactive
MMP-2 forms on uncoated plates (f). Data represent mean ± standard
deviation (SD). **p<0.01 compared with static condition (−CML).
Release of TIMP-2 by fibroblasts on collagen substrates (g). Low-
serum media that was not exposed to cells was used as negative
control. Positive controls used: for zymograms, human recombinant
MMP-2; for Western blot, cell lysates from dermal stem cells

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POP, and mechanical loading down-regulated collagen I
on healthy fibroblasts only. Changes seen with cataboli-
cally secreted proteins were not correlated at gene-
expression levels. Such discrepancy emphasizes the im-
portance of using different evaluation parameters because
changes at gene expression levels do not necessarily
reflect changes at protein levels, and they can occur at
different times.
Taken together, our data suggest that although fibroblasts
from POP patients seem to have lower mechanoresponses,
in the presence of collagen-I substrate, the system eventual-
ly reaches a balance. This latter finding confirms 48-h data
from Zong and colleagues [22], who used collagen-I-coated
plates in their dynamic in vitro model with similar experi-
mental conditions (sinus wave; amplitudes 8 % and 16 %;
frequency 1 Hz), and found no differences between healthy
and mild and severe POP vaginal fibroblasts. However, it
appears that when cells are exposed to artificial polymeric
substrates and stress is imposed, this balance is not reached.
Fibroblasts from women with POP seem preconditioned by
the abnormal prolapsed matrix. Unable to respond in the
same way as control cells, POP fibroblasts might not be able
to restore ECM homeostasis when artificial polymeric sub-
strates are added to their microenvironment. In such circum-
stances, tissue remodelling might not be restored but, rather,
may in turn provide a negative feedback loop that deterio-
rates the ECM even further, leading to an additional loss of
strength, increased stiffness, and eventually more tissue
damage. Such implications at the micro level are in line
with findings at the macro level. Several studies report
increased stiffness in prolapsed tissues when assessing bio-
mechanical properties of the vaginal wall from patients with
POP compared with healthy controls [17–19]. Moreover, it
has also been shown that polymeric mesh used in genital
prolapse surgery is stiffer than native tissue [23]. Feola and
colleagues [24] showed correlation between mesh stiffness
and tissue deterioration in a nonprimate animal model.
Therefore, changes in the vaginal wall at the cellular level
could be good indicators of tissue behavior and should be
taken into account when using polymeric mesh to treat
patients. As surface substrate affects cellular behavior, and
cell–matrix interactions seem to be impaired in POP fibro-
blasts, improving mesh surface characteristics could en-
hance implant integration.
Conclusions from this study should be treated with care:
results were obtained in an in vitro setup, which allowed us
to control certain parameters but does not fully reflect the in
vivo situation. Furthermore, we are aware that our patient
population was too small to draw conclusions about all
women with POP. The experiments were repeated three
times, all confirming the first results and suggesting our
model is valid. We are in the process of expanding our
sample size.
To improve pelvic floor treatment, further studies evalu-
ating the effect on fibroblasts of different ECM proteins in
dynamic in vitro systems could provide important clues to
improve mesh designs before using animals for in vivo
studies and humans for clinical trials. This approach should
provide better clinical outcomes by using information from
bench to bedside to restore pelvic support and improve
host–implant integration when treating POP.
In summary, this study provides a model by which to
evaluate dynamic interactions of fibroblasts from the pelvic
floor with artificial substrates in vitro. Unlike previous
models [21, 22], we chose a continuous physiological
stretching regimen to compare fibroblast mechanoresponses
to artificial collagen-I-coated and uncoated substrates. We
thereby show clear differences between POP and healthy
fibroblasts on artificial polymer substrates. This emphasizes
the importance of evaluating cell–matrix interactions with
different surroundings to better understand the influences in
dynamic environments of proteins from the ECM on vaginal
fibroblast behavior. Such outcomes may provide important
clues for designing biomesh that appropriately mimics the
ECM environment, as it seems that the addition of collagen
coating helps restore vaginal-wall metabolic balance. This
new approach may thus improve treatment for POP.
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